Rivastigmine in Mild Alzheimer's Disease, FMRI Study

Summary

The purpose of the study is to investigate the effect of rivastigmine given as an acute dose compared to placebo and after 1 month chronic dosing on fMRI response during a face recognition task. Furthermore, the aim is to investigate whether fMRI response is correlated with long term treatment effect at 6 months and 12 months.

Timeline

Start

2007-03

Primary completion

2008-12

Completion

2008-12

Drugs

Indications